Navigation Links
Concord Medical Declares Special Dividend
Date:7/28/2011

BEIJING, July 28, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that on July 26, 2011 its Board of Directors declared a special dividend of $0.06 per ordinary share (or $0.18 per American Depositary Share) on the Company's outstanding ordinary shares. The total expense for the special dividend is expected to be about US$8.5 million, based on the 142,353,532 ordinary shares that were outstanding as of July 28, 2010. Each ADS represents three ordinary shares of the Company.

The dividends are payable on September 30, 2011, to shareholders of record at the close of business on August 31, 2011. This is the Company's first dividend declared on its ordinary shares since its initial public offering on December 11, 2009. The underwriters for the IPO were Morgan Stanley, J.P. Morgan, and CICC.

Mr. Steve Sun, co-chairman and chief financial officer, said, "The Board of Directors declared this special dividend to provide shareholders with a tangible recognition of our good growth and financial performance since our initial public offering in December 2009. The Board expects to establish a long-term dividend policy, after a thorough analysis of the company's long-term strategy, plans, outlook, and anticipated cash needs."

Safe Harbor StatementThis news release may contain forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project,"
'/>"/>

SOURCE Concord Medical Services Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Concord Medical Services Files 2010 Annual Report on Form 20-F
2. Concord Medical Announces First Quarter 2011 Financial Results
3. Concord Medical Services Holdings to Present at Two Upcoming Conferences
4. Concord Medical to Report First Quarter 2011 Financial Results on Wednesday, May 18, 2011
5. Concord Medical to Report Fourth Quarter and Fiscal Year 2010 Financial Results on Monday, March 28, 2011
6. Concord Medical Services Holdings to Present at Two Upcoming Conferences
7. Concord Medical to Hold Annual General Meeting on December 11, 2010
8. Concord Medical Announces Second Quarter 2010 Financial Results
9. Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010
10. Concord Medical Enters into Joint Venture Agreement with ChangAn Hospital
11. Concord Medical Files 2009 Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015 /PRNewswire-USNewswire/ -- ... prescription drug abuse and doctor shopping after a 2012 ... prescribing powerful and addictive medications is yet more evidence ... today. Since Kentucky,s ... of patients "doctor shopping" declined by 52 percent; opioid ...
(Date:7/28/2015)... DUBLIN , July 21, 2015 ... ) has announced the addition of the ... Share, Growth, Trends and Forecast 2014 - 2022" ... report on the craniomaxillofacial implants market studies the ... Craniomaxillofacial implants are rapidly gaining popularity in the ...
(Date:7/28/2015)... July 28, 2015 According to ... by Type (Dermatology Treatment Devices, and Dermatology Diagnostic Devices ... Application, by Geography - Analysis and Forecast to 2019", ... $11.88 billion by 2019, at a CAGR of 10.4% ... TOC of Global Dermatology Devices Market for an in-depth ...
Breaking Medicine Technology:Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3
... Reportlinker.com announces that a new market ... Germany Surgical Equipment Market ... http://www.reportlinker.com/p0254518/Germany-Surgical-Equipment-Market-Outlook-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Germany Surgical Equipment ... Summary GlobalData,s new report, ...
... OSLO, Norway, October 31, 2011 Oslo ... oncology. The true strength of the Norwegian cluster lies ... than the ones available to cancer patients today. ... cluster within the field of oncology, dedicated to accelerating ...
Cached Medicine Technology:Germany Surgical Equipment Market Outlook to 2016 2Germany Surgical Equipment Market Outlook to 2016 3Germany Surgical Equipment Market Outlook to 2016 4Germany Surgical Equipment Market Outlook to 2016 5Germany Surgical Equipment Market Outlook to 2016 6Germany Surgical Equipment Market Outlook to 2016 7Germany Surgical Equipment Market Outlook to 2016 8Germany Surgical Equipment Market Outlook to 2016 9Expanding Norwegian Cluster of Excellence Dedicated to Oncology 2Expanding Norwegian Cluster of Excellence Dedicated to Oncology 3
(Date:7/29/2015)... , ... July 29, 2015 , ... Attorneys representing American ... Powder Cancer Lawsuit Center. The website now features a page dedicated to news related ... from other sources. The Talcum Powder Lawsuit News page was launched with ...
(Date:7/29/2015)... ... ... mybody ” was featured on NewsWatch as part of its monthly Biz Report, which ... industry. Andrew Tropeano, the host of NewsWatch and business expert, conducted the business review ... the skin’s defense system from the inside out. , According to Statista, the global ...
(Date:7/29/2015)... ... July 29, 2015 , ... People that are passionate about gardening ... on Mercola.com: a vertical “garden tower” and enhanced mineral product for growing ideal crops. ... corners on a porch, balcony, or rooftop – can hold up to 100 plants ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... ... , ... Nature’s Artisan, a new holistic oral care company, has released a ... founded by Tina Yarandi, who came up with the idea for the product line ... amazed when she learned about the incredible dental benefits of xylitol, but was disappointed ...
Breaking Medicine News(10 mins):Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... Data Show Activity in First- and Late-Line Treatment of ... EXEL ),reported data from three clinical trials of ... VEGFR2, at the 44th Annual Meeting of the,American Society ... 2 trial in previously untreated, clinically selected non-small cell,lung ...
... Colo., June 2 Baxa Corporation announces the,launch ... Academics and,Resources (STAR) Center in Englewood, Colorado. The ... the expanding course offerings,at the Baxa facility. Currently, ... state-of-the-art cleanroom training facility. Baxa expects,to continue adding ...
... June 2 American Oriental,Bioengineering (NYSE: AOB ... has,authorized a share repurchase program for the repurchase ... common stock., Purchases under this program may ... market, privately negotiated transactions, and accelerated stock,repurchase transactions ...
... product development and clinical evaluation activities, ... Inc., a privately,held company developing and commercializing ... life science, biodefense, environmental,testing, point-of-care diagnostics and ... been awarded a $996,000 contract by the ...
... ... WHO: Valley Forge Medical Center & Hospital, WHERE: ... ... Forge Medical Center and,Hospital is the first facility on the East Coast to obtain the,Addiction-Free Pain ...
... TraderNotes on stocks that are making news today., ... for free by visiting:, http://www.BeaconEquity.com/m , Today,s TraderNotes ... (Nasdaq: RXII ), Vion Pharmaceuticals Inc.,(Nasdaq: VION ... (Nasdaq: AMGN ),Gilead Sciences Inc. (Nasdaq: GILD ...
Cached Medicine News:Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:Baxa Launches New Microsite for STAR Center Training Facility 2Health News:American Oriental Bioengineering Announces US$75 Million Share Repurchase Program 2Health News:Cantimer, Inc. Awarded $996,000 Contract from U.S. Government to Develop Portable, Real-Time and Non-Invasive Hydration Measurement and Monitoring System for Use by Firefighters 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 3Health News:BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR 2Health News:BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: